Stonepine Capital Management, LLC 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:06 pm Sale | 2020-12-31 | 13G | Interpace Biosciences, Inc. IDXG | Stonepine Capital Management, LLC | 0 0.000% | -277,277 (Position Closed) | Filing |
| 2020-09-11 4:34 pm Purchase | 2020-09-03 | 13G | Interpace Biosciences, Inc. IDXG | Stonepine Capital Management, LLC | 277,277 6.900% | 169,517 (+157.31%) | Filing |